Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
Bangladesh · Delayed Price · Currency is BDT 52.30
-1.20 (-2.24%)
At close: Nov 3, 2025
Navana Pharmaceuticals Market Cap
Navana Pharmaceuticals has a market cap or net worth of 5.62 billion as of November 3, 2025. Its market cap has increased by 1.55% in one year.
Market Cap
5.62B
Enterprise Value
10.35B
Revenue
8.47B
Ranking
n/a
PE Ratio
12.54
Stock Price
52.30
Market Cap Chart
Since October 18, 2022, Navana Pharmaceuticals's market cap has increased from 2.84B to 5.62B, an increase of 98.11%. That is a compound annual growth rate of 25.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 5.62B | 7.61% |
| Dec 30, 2024 | 5.22B | -42.42% |
| Dec 28, 2023 | 9.07B | 7.79% |
| Dec 29, 2022 | 8.41B | 196.59% |
| Oct 18, 2022 | 2.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grameenphone | 382.68B |
| Square Pharmaceuticals PLC. | 189.52B |
| Robi Axiata PLC. | 155.04B |
| British American Tobacco Bangladesh Company | 137.65B |
| Walton Hi-Tech Industries | 137.45B |
| BRAC Bank PLC. | 135.58B |
| Bangladesh Export Import Company | 103.85B |
| Marico Bangladesh | 87.58B |